PAVS vs TAOP vs GFAI vs AIXI vs XTLB

For growth investors, Xiao-I Corporation (AIXI) is the stronger pick with 18.

8% revenue growth year-over-year, versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, XTL Biopharmaceuticals Ltd.

(XTLB) delivered a total return of -80. 4%, compared to -100. 0% for Paranovus Entertainment Technology Ltd. (PAVS). Over 10 years, the gap is even starker: XTLB returned -87. 3% versus PAVS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Xiao-I Corporation (AIXI) is the lower-risk stock at 0.

94β versus Guardforce AI Co. , Limited's 2. 31β — meaning GFAI is approximately 145% more volatile than AIXI relative to the S&P 500. On balance sheet safety, XTL Biopharmaceuticals Ltd. (XTLB) carries a lower debt/equity ratio of 3% versus 50% for Taoping Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Xiao-I Corporation (AIXI) is pulling ahead at 18.

8% versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). On earnings-per-share growth, the picture is similar: Paranovus Entertainment Technology Ltd. grew EPS 96. 4% year-over-year, compared to -1870. 0% for Taoping Inc.. Over a 3-year CAGR, AIXI leads at 29. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Guardforce AI Co.

, Limited (GFAI) is the more profitable company, earning -16. 1% net margin versus -110. 3% for Paranovus Entertainment Technology Ltd. — meaning it keeps -16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AIXI leads at -18. 3% versus -94. 8% for PAVS. At the gross margin level — before operating expenses — AIXI leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Xiao-I Corporation (AIXI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

94)). Taoping Inc. (TAOP) carries a higher beta of 2. 30 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AIXI: -98. 6%, TAOP: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PAVS (Consumer Defensive) and TAOP (Technology) and GFAI (Industrials) and AIXI (Technology) and XTLB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PAVS is a small-cap quality compounder stock; TAOP is a small-cap quality compounder stock; GFAI is a small-cap quality compounder stock; AIXI is a small-cap high-growth stock; XTLB is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.